# Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?

> **NCT03347513** · PHASE4 · UNKNOWN · sponsor: **Kasr El Aini Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Pregnancy Complications
- Anemia, Iron Deficiency
- H Pylori Infection

## Interventions

- **DRUG:** triple attack therapy
- **DRUG:** Ferrous(II)-glycine-sulphate complex 567.7 mg capsules

## Key facts

- **NCT ID:** NCT03347513
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-25
- **Primary completion:** 2019-03
- **Final completion:** 2019-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03347513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03347513, "Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03347513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*